Market-oriented, scientific research, clinical practice, production and marketing are integrated, and modern high-tech is used to study traditional Chinese medicine and biological drugs for treating difficult diseases. In the process of development, the group company has accumulated a profound corporate culture and gathered a large number of innovative and professional medical doctors, masters and other high-tech talents. The Postdoctoral Research Center of the Ministry of Personnel has made remarkable achievements in the research, development and production of modern Chinese medicine and biopharmaceuticals with its high-quality talent team and high-tech and equipment platform. Relying on its own institutional advantages, the company has realized industrialization and internationalization, and developed into a modern pharmaceutical group with great influence in China and five branches. In the new century, Yiling people will continue to carry forward the enterprise spirit of "unity, forge ahead, honesty and dedication", take the revitalization of national medicine as their own responsibility, strive to build a brand of traditional Chinese medicine, keep up with the forefront of medical science and technology, build international leading products, build a platform for science and technology and market, sincerely cooperate with friends from all walks of life, and strive to achieve the grand goal of "joining in science and technology and having a healthy tomorrow". Yiling Pharmaceutical Co., Ltd., located in Shijiazhuang High-tech Development Zone, Hebei Province, was founded on 1992 by Professor Wu Yiling, academician of China Academy of Engineering, chief scientist of National 973 Project and doctoral supervisor. After more than ten years' development, it has become a modern pharmaceutical high-tech industrial group with six branches, including Yiling Pharmaceutical Research Institute, Shijiazhuang Yiling Pharmaceutical Co., Ltd., Hebei Yiling Hospital, Anguo Yiling Chinese Herbal Pieces Co., Ltd., Beijing Yiling Pharmaceutical Co., Ltd. and Beijing Yiling Biological Co., Ltd., which integrates scientific research, teaching, clinic, production and marketing. It is one of the top 100 pharmaceutical enterprises in China, and the national independent innovation capability of Chinese patent medicine manufacturing industry is 10. It has won hundreds of honorary titles such as national key high-tech enterprises, leading pharmaceutical manufacturing enterprises, social responsibility contribution award of pharmaceutical enterprises, honest enterprises in Hebei Province and most socially responsible enterprises in Hebei Province. Yiling Pharmaceutical insists on taking science and technology as the guide, taking the market as the leading factor, promoting the industrialization of traditional Chinese medicine with academic innovation of traditional Chinese medicine, and using modern high technology to research and develop traditional Chinese medicine, western medicine and biomedicine. Relying on Yiling Medical Research Institute, it has been recognized by the state as the national enterprise technology center, postdoctoral research center, national 863 achievement transformation base, the first batch of international scientific and technological cooperation bases, Hebei new Chinese medicine R&D and achievement industrialization center, and Shijiazhuang compound Chinese medicine engineering R&D center. He has successively undertaken more than 30 national, provincial and ministerial-level projects such as National 973, National 863, National Tenth Five-Year Plan and National Natural Science Foundation, won more than 0/00 domestic and foreign invention patents, and won more than 20 national, provincial and ministerial-level scientific and technological awards such as the second prize of national scientific and technological progress and the second prize of national technological invention. A series of national new drugs with independent intellectual property rights were developed and rapidly industrialized, and a new way to accelerate the development of traditional Chinese medicine through academic innovation was found. Yiling Pharmaceutical has formed a product group mainly consisting of Tongxinluo Capsule, Shen Song Yangxin Capsule and Lianhua Qingwen Capsule, and listed 9 patented new drugs and 100 generic drugs. Subsequent research and development will make the product series more perfect. Tongxinluo capsule is the only Chinese patent medicine for treating cardiovascular and cerebrovascular diseases that has won three national awards in China. It has become the leading brand of Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, ranking the top three in the domestic market. Lianhua Qingwen Capsule is a high-tech demonstration project of the National Development and Reform Commission and a national OTC A variety, which has played an important role in fighting against SARS, avian influenza and the current global influenza A epidemic ... A lot of scientific research by a number of authoritative scientific research machines in China has proved that it can be broad-spectrum antiviral, effectively antibacterial, antipyretic and anti-inflammatory, effectively improving symptoms such as fever, sore throat and cough, enhancing immunity and improving the body's disease resistance. The anti-influenza effect of influenza A virus H 1N 1 is better than Tamiflu. Shen Song Yangxin Capsule is the only Chinese patent medicine to carry out clinical research on antiarrhythmia of evidence-based medicine in China. Its clinical efficacy and safety have been unanimously recognized by medical experts and consumers, which has played a positive demonstration role in the modernization and internationalization of clinical research of traditional Chinese medicine in China. Yiling pharmaceutical research institute is the leader of the development of the group company, and has built a modern high-tech research and development platform in line with GLP standards. There are more than 0/00 researchers/kloc, 8 overseas doctors and postdoctoral students/kloc, 27 masters, and 35 sub-majors or above. Cooperate with academicians and experts from well-known universities and research institutes at home and abroad to carry out R&D projects, and its strong talent team has provided strong technical support for new drug research and development for more than ten years. Yiling Medical College consists of pharmacy department, pharmaceutical science department, clinical department and registered patent department. It is equipped with world-advanced analytical instruments such as high performance liquid chromatography, gas chromatography, thin-layer scanning, atomic absorption, nuclear magnetic resonance, infrared spectrum and gas chromatography-mass spectrometry, as well as advanced process research equipment and complete pilot plant such as supercritical extraction, adsorption separation, membrane separation and nano-preparation. The research system of extraction, separation and purification of effective components or effective parts of modern Chinese medicine and the quality control system of fingerprint of Chinese medicine were established. Yiling Pharmaceutical Research Institute has the research and development ability of Chinese medicine compound, Chinese medicine monomer, Chinese medicine components compatible with various new drugs and western medicine trauma-like drugs, and has become an influential drug research and development institution in China. Shijiazhuang Yiling Pharmaceutical Co., Ltd. has production lines for capsules, soft capsules, tablets, granules, injections and dripping pills that have passed GMP and ISO900 1 quality system certification, as well as chemical workshops that meet EU certification standards and are guided by foreign experts, with an annual output value of 5 billion yuan. Yiling Pharmaceutical Co., Ltd. introduced advanced equipment and technology in all aspects of large-scale production of traditional Chinese medicine, and adopted advanced technologies such as dynamic extraction, external circulation concentration, supercritical CO2 extraction, high-speed centrifugal spray drying and one-step granulation to improve the quality of modern traditional Chinese medicine. Tsinghua University * * * undertook the national high-tech development plan project-Tongxinluo Capsule Ultrafine Powder Process Upgrade Project, which successfully applied ultrafine powder technology to the production of Chinese patent medicines for the first time, became a national standard and won a national award. Modern production line, reliable product quality and strong production capacity ensure that scientific research results can be quickly transformed into high-quality new products to be put on the market. Yiling Chinese Herbal Pieces Co., Ltd. is the raw material base of Yiling Pharmaceutical Group. The company is located in Anguo, the drug capital, with an area of 20,000 square meters and a building area of 10000 square meters. It is a modern enterprise integrating standardized cultivation of medicinal materials, processing and trade of Chinese herbal pieces and refined Chinese herbal pieces. In 2004, it was the first to pass the GMP certification of Chinese herbal pieces by the State Food and Drug Administration of the United States. In order to ensure the quality of raw materials, the company has established planting and breeding bases that meet GAP requirements in Anguo, Jilin, Gucheng and other places, and established QA and QC quality assurance systems. At the same time, Yinpian Company has carried out the processing and sales of traditional Chinese medicine Yinpian, and established good business relations with thousands of hospitals and pharmaceutical companies.